查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1288782

全球人口篩查市場研究報告 - 行業分析、規模、佔有率、成長、趨勢和2023年至2030年預測

Global Population Screening Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 339 Pages | 商品交期: 最快1-2個工作天內

價格

到2030年，全球人口篩查市場的需求將從2022年的35.3百萬美元達到近6757百萬美元的市場規模，在2023-2030年的研究期間，複合年成長率為7.48%。

人口篩查是指對一大群人（通常是特定人群）進行系統測試，以確定是否存在某種疾病或健康狀況。人口篩查的目標是在早期階段發現疾病或狀況，這時的治療更有效，可以帶來更好的健康結果。人口篩查可以涉及各種測試，包括血液測試、成像測試和身體檢查。人口篩查項目的例子包括乳房X光檢查（乳腺癌）、巴氏塗片檢查（宮頸癌）和結腸鏡檢查（結腸癌）。人口篩查也可用於確定某些疾病的風險因素，如心臟病的膽固醇和血壓篩查。人口篩查項目通常由醫療服務提供者或公共衛生機構組織和實施，通常由政府資金支持。人口篩查項目的設計和實施會因所針對的疾病或狀況、被篩查人群的特徵以及現有的篩查方法和技術而有所不同。雖然人口篩查是在早期階段發現疾病和病症的有效方法，但它也可能有缺點。例如，一些篩查測試可能產生假陽性或假陰性的結果，促使不必要的擔心或錯過診斷。此外，一些人可能出於各種原因選擇不參加篩查項目，包括缺乏機會或擔心隱私或後續護理費用。

市場動態：

人群篩查計劃可以説明在早期階段發現慢性病，此時治療更有效，從而在減輕這些疾病的負擔方面發揮重要作用。技術和篩查方法的進步使人群篩查計劃更加準確、高效和具有成本效益。例如，新的成像技術和生物標誌物測試正在實現更早和更準確的疾病檢測。世界上許多政府都認識到人口篩查計劃的重要性，並正在提供資金和支援以擴大這些計劃。這推動了人口篩查市場的增長。隨著人們意識到人群篩查的好處以及篩查計劃的準確性和有效性的提高，這些計劃的接受和接受正在增加。隨著人們尋求保持健康和預防疾病的發作，預防性醫療保健的趨勢越來越明顯。人口篩查計劃是預防保健的重要組成部分，因此對這些計劃的需求正在增加。

該研究報告涵蓋了波特的五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清楚地瞭解行業結構，並在全球範圍內評估競爭吸引力。此外，這些工具還對全球人口篩查市場的每個市場區隔進行了包容性評估。人口篩查行業的增長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋了區域前景，強調了北美、歐洲、亞太、拉丁美洲、中東和非洲地區人口篩查市場的當前和未來需求。此外，該報告重點關注所有突出地區的個別應用部分的需求、估計和預測。

該研究報告還涵蓋了市場中主要參與者的全面概況和對全球競爭格局的深入看法。人口篩選市場的主要參與者包括安捷倫科技公司、賽默飛世爾科技公司、QIAGEN、F. Hoffmann-La Roche Ltd.、Quest Diagnostics、Illumina Inc.、ARUP Laboratories、Novogene Co.Ltd., LGC Limited, Gene by Gene Ltd.這一部分包括對競爭格局的整體看法，其中包括各種戰略發展，如主要的合併和收購、未來的能力、夥伴關係、財務概況、合作、新產品的開發、新產品的推出以及其他發展。

目錄

第1章：前言

  • 報告描述
    • 目的
    • 目標受眾
    • 獨特的銷售主張（USP）和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法

第二章：執行摘要

  • 市場的亮點
  • 全球市場簡介

第三章：人口普查- 行業分析

  • 簡介- 市場動態
  • 市場驅動力
  • 市場限制因素
  • 機會
  • 行業趨勢
  • 波特的五力分析
  • 市場吸引力分析
    • 按地域分類的市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按業務分類的市場吸引力分析
    • 按性別分類的市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按年齡分類的市場吸引力分析
    • 市場吸引力分析：按地區

第四章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商名單
    • 關鍵原料的價格趨勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道的發展趨勢

第五章：Covid-19爆發的影響分析

第六章：全球人口篩查市場分析：按地理區域分類

  • 按地理區域概述
  • 歷史和預測數據
  • 按地理區域分析
  • 國家
  • 國家

第7章：全球人口篩查市場分析：按產品

  • 按產品概述
  • 歷史和預測數據
  • 按產品分析
  • 硬體設備（儀器、套件、晶片）
  • 測試/實驗室（服務）
  • 分析/解釋（個性化和解釋）

第八章：全球人口篩查市場分析：按業務分類

  • 按業務概述
  • 歷史和預測數據
  • 按業務分析
  • 醫院
  • 研究機構
  • 診斷實驗室

第九章：全球人口篩查市場分析：按性別分類

  • 按性別概述
  • 歷史和預測數據
  • 按性別分析
  • 男性
  • 女性

第十章：全球人口篩查市場分析：按類型分類

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 大眾
  • 溢價

第十一章：全球人口篩查市場分析：按年齡

  • 按年齡分類的概述
  • 按年齡分類的
  • 歷史和預測
  • 數據分析
  • 年齡<15歲按地區分類的歷史和預測銷售額
  • 15-65
  • 歲65歲以上

第十二章：全球人口篩查市場銷售分析：按地理區域分類

  • 區域展望
  • 簡介
  • 北美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 北美地區分部銷售分析
    • 北美地區國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概況、歷史和預測的銷售分析
    • 歐洲分部銷售分析
    • 歐洲國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概況、歷史和預測的銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉美地區銷售分析
    • 概況、歷史和預測的銷售分析
    • 拉美地區分部銷售分析
    • 拉美地區國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概況、歷史和預測銷售分析
    • 中東和非洲地區分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 其他中東和非洲國家銷售分析

第十三章：人口篩查公司的競爭格局

  • 人口篩查市場競爭
  • 夥伴關係/合作/協議
  • 合併和收購
  • 新產品發布
  • 其他方面的發展

第14章：公司簡介

  • 頂級公司佔有率分析
  • 市場集中度
  • Agilent Technologies Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • QIAGEN
    • 公司概覽
    • 公司收入
    • 產品
    • 近期發展
  • F. Hoffmann-La Roche Ltd.
    • 公司概覽
    • 公司收入
    • 產品
    • 近期發展
  • Quest Diagnostics
    • 公司概覽
    • 公司收入
    • 產品
    • 近期發展
  • Illumina Inc.
    • 公司概覽
    • 公司收入
    • 產品
    • 近期發展
  • ARUP Laboratories
    • 公司概覽
    • 公司收入
    • 產品
    • 近期發展
  • Novogene Co. Ltd.
    • 公司概覽
    • 公司收入
    • 產品
    • 近期發展
  • LGC Limited
    • 公司概覽
    • 公司收入
    • 產品
    • 近期發展
  • Gene Gene Ltd.
    • 公司概覽
    • 公司收入
    • 產品
    • 近期發展情況

注意- 在公司簡介中，財務細節和最近的發展情況取決於可用性，可能不包括私人公司在內。

Product Code: VMR112110525

The global demand for Population Screening Market is presumed to reach the market size of nearly USD 67.57 BN by 2030 from USD 35.3 BN in 2022 with a CAGR of 7.48% under the study period 2023-2030.

Population screening refers to the systematic testing of a large group of individuals, typically a specific population, to identify the presence of a particular disease or health condition. The goal of population screening is to detect the disease or condition at an early stage when treatment is more effective and can lead to better health outcomes. Population screening can involve a variety of tests, including blood tests, imaging tests, and physical exams. Examples of population screening programs include mammography screening (breast cancer, Pap smear screening (cervical cancer), and colonoscopy screening(colon cancer). Population screening can also be used to identify risk factors for certain diseases, such as cholesterol and blood pressure screening for heart disease. Population screening programs are typically organized and implemented by healthcare providers or public health agencies, often with support from government funding. The design and implementation of population screening programs can vary depending on the disease or condition being targeted, the characteristics of the population being screened, and the available screening methods and technology. While population screening can be an effective way to identify diseases and conditions at an early stage, it can also have drawbacks. For example, some screening tests can produce false-positive or false-negative results, leading to unnecessary worry or missed diagnoses. Additionally, some individuals may choose not to participate in screening programs for various reasons, including lack of access or concerns about privacy or the cost of follow-up care.

Market Dynamics:

Population screening programs can help to detect chronic diseases at an early stage, when treatment is more effective, and thus play an important role in reducing the burden of these diseases. Advances in technology and screening methods are making population screening programs more accurate, efficient, and cost-effective. For example, new imaging technologies and biomarker tests are enabling earlier and more accurate detection of diseases. Many governments around the world are recognizing the importance of population screening programs and are providing funding and support to expand these programs. This is driving the growth of the population screening market. As people become aware of the benefits of population screening and the accuracy and efficacy of screening programs improve, the acceptance and uptake of these programs are increasing. There is a growing trend towards preventive healthcare, as people seek to maintain their health and prevent the onset of diseases. Population screening programs are an important part of preventive healthcare, and the demand for these programs is therefore increasing.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of population screening. The growth and trends of population screening industry provide a holistic approach to this study.

Market Segmentation:

This section of the population screening market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Geography

  • Nation
  • State

By Product

  • Hardware Equipment (Instrument, Kits, Chips)
  • Testing / Lab (Services)
  • Analytics / Interpretation (Personalization And Interpretation)

By Business

  • Hospitals
  • Research Institutes
  • Diagnostic Labs

By Gender

  • Male
  • Female

By Type

  • Mass
  • Premium

By Age

  • Ages <15
  • 15-65
  • Ages 65+

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Population Screening market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the population screening market include Agilent Technologies Inc., Thermo Fisher Scientific, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Quest Diagnostics, Illumina Inc., ARUP Laboratories, Novogene Co. Ltd., LGC Limited, Gene by Gene Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . POPULATION SCREENING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Geography
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Business
    • 3.7.4 Market Attractiveness Analysis By Gender
    • 3.7.5 Market Attractiveness Analysis By Type
    • 3.7.6 Market Attractiveness Analysis By Age
    • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY GEOGRAPHY

  • 6.1 Overview by Geography
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Geography
  • 6.4 Nation Historic and Forecast Sales by Regions
  • 6.5 State Historic and Forecast Sales by Regions

7 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY PRODUCT

  • 7.1 Overview by Product
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Product
  • 7.4 Hardware Equipment (Instrument, Kits, Chips) Historic and Forecast Sales by Regions
  • 7.5 Testing / Lab (Services) Historic and Forecast Sales by Regions
  • 7.6 Analytics / Interpretation (Personalization And Interpretation) Historic and Forecast Sales by Regions

8 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY BUSINESS

  • 8.1 Overview by Business
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Business
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Research Institutes Historic and Forecast Sales by Regions
  • 8.6 Diagnostic Labs Historic and Forecast Sales by Regions

9 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY GENDER

  • 9.1 Overview by Gender
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Gender
  • 9.4 Male Historic and Forecast Sales by Regions
  • 9.5 Female Historic and Forecast Sales by Regions

10 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY TYPE

  • 10.1 Overview by Type
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Type
  • 10.4 Mass Historic and Forecast Sales by Regions
  • 10.5 Premium Historic and Forecast Sales by Regions

11 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY AGE

  • 11.1 Overview by Age
  • 11.2 Historical and Forecast Data
  • 11.3 Analysis by Age
  • 11.4 Ages <15 Historic and Forecast Sales by Regions
  • 11.5 15-65 Historic and Forecast Sales by Regions
  • 11.6 Ages 65+ Historic and Forecast Sales by Regions

12 . GLOBAL POPULATION SCREENING MARKET SALES ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America Sales Analysis
    • 12.3.1. Overview, Historic and Forecast Sales Analysis
    • 12.3.2. North America By Segment Sales Analysis
    • 12.3.3. North America By Country Sales Analysis
    • 12.3.4. United State Sales Analysis
    • 12.3.5. Canada Sales Analysis
    • 12.3.6. Mexico Sales Analysis
  • 12.4. Europe Sales Analysis
    • 12.4.1. Overview, Historic and Forecast Sales Analysis
    • 12.4.2. Europe by Segment Sales Analysis
    • 12.4.3. Europe by Country Sales Analysis
    • 12.4.4. United Kingdom Sales Analysis
    • 12.4.5. France Sales Analysis
    • 12.4.6. Germany Sales Analysis
    • 12.4.7. Italy Sales Analysis
    • 12.4.8. Russia Sales Analysis
    • 12.4.9. Rest Of Europe Sales Analysis
  • 12.5. Asia Pacific Sales Analysis
    • 12.5.1. Overview, Historic and Forecast Sales Analysis
    • 12.5.2. Asia Pacific by Segment Sales Analysis
    • 12.5.3. Asia Pacific by Country Sales Analysis
    • 12.5.4. China Sales Analysis
    • 12.5.5. India Sales Analysis
    • 12.5.6. Japan Sales Analysis
    • 12.5.7. South Korea Sales Analysis
    • 12.5.8. Australia Sales Analysis
    • 12.5.9. Rest Of Asia Pacific Sales Analysis
  • 12.6. Latin America Sales Analysis
    • 12.6.1. Overview, Historic and Forecast Sales Analysis
    • 12.6.2. Latin America by Segment Sales Analysis
    • 12.6.3. Latin America by Country Sales Analysis
    • 12.6.4. Brazil Sales Analysis
    • 12.6.5. Argentina Sales Analysis
    • 12.6.6. Peru Sales Analysis
    • 12.6.7. Chile Sales Analysis
    • 12.6.8. Rest of Latin America Sales Analysis
  • 12.7. Middle East & Africa Sales Analysis
    • 12.7.1. Overview, Historic and Forecast Sales Analysis
    • 12.7.2. Middle East & Africa by Segment Sales Analysis
    • 12.7.3. Middle East & Africa by Country Sales Analysis
    • 12.7.4. Saudi Arabia Sales Analysis
    • 12.7.5. UAE Sales Analysis
    • 12.7.6. Israel Sales Analysis
    • 12.7.7. South Africa Sales Analysis
    • 12.7.8. Rest Of Middle East And Africa Sales Analysis

13 . COMPETITIVE LANDSCAPE OF THE POPULATION SCREENING COMPANIES

  • 13.1. Population Screening Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14 . COMPANY PROFILES OF POPULATION SCREENING INDUSTRY

  • 14.1. Top Company Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Agilent Technologies Inc.
    • 14.3.1. Company Overview
    • 14.3.2. Company Revenue
    • 14.3.3. Products
    • 14.3.4. Recent Developments
  • 14.4. Thermo Fisher Scientific Inc.
    • 14.4.1. Company Overview
    • 14.4.2. Company Revenue
    • 14.4.3. Products
    • 14.4.4. Recent Developments
  • 14.5. QIAGEN
    • 14.5.1. Company Overview
    • 14.5.2. Company Revenue
    • 14.5.3. Products
    • 14.5.4. Recent Developments
  • 14.6. F. Hoffmann-La Roche Ltd.
    • 14.6.1. Company Overview
    • 14.6.2. Company Revenue
    • 14.6.3. Products
    • 14.6.4. Recent Developments
  • 14.7. Quest Diagnostics
    • 14.7.1. Company Overview
    • 14.7.2. Company Revenue
    • 14.7.3. Products
    • 14.7.4. Recent Developments
  • 14.8. Illumina Inc.
    • 14.8.1. Company Overview
    • 14.8.2. Company Revenue
    • 14.8.3. Products
    • 14.8.4. Recent Developments
  • 14.9. ARUP Laboratories
    • 14.9.1. Company Overview
    • 14.9.2. Company Revenue
    • 14.9.3. Products
    • 14.9.4. Recent Developments
  • 14.10. Novogene Co. Ltd.
    • 14.10.1. Company Overview
    • 14.10.2. Company Revenue
    • 14.10.3. Products
    • 14.10.4. Recent Developments
  • 14.11. LGC Limited
    • 14.11.1. Company Overview
    • 14.11.2. Company Revenue
    • 14.11.3. Products
    • 14.11.4. Recent Developments
  • 14.12. Gene Gene Ltd.
    • 14.12.1. Company Overview
    • 14.12.2. Company Revenue
    • 14.12.3. Products
    • 14.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Geography (USD MN)
  • Nation Market Sales by Geography (USD MN)
  • State Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Hardware Equipment (Instrument, Kits, Chips) Market Sales by Geography (USD MN)
  • Testing / Lab (Services) Market Sales by Geography (USD MN)
  • Analytics / Interpretation (Personalization And Interpretation) Market Sales by Geography (USD MN)
  • Analysis by Business (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Research Institutes Market Sales by Geography (USD MN)
  • Diagnostic Labs Market Sales by Geography (USD MN)
  • Analysis by Gender (USD MN)
  • Male Market Sales by Geography (USD MN)
  • Female Market Sales by Geography (USD MN)
  • Analysis by Type (USD MN)
  • Mass Market Sales by Geography (USD MN)
  • Premium Market Sales by Geography (USD MN)
  • Analysis by Age (USD MN)
  • Ages <15 Market Sales by Geography (USD MN)
  • 15-65 Market Sales by Geography (USD MN)
  • Ages 65+ Market Sales by Geography (USD MN)
  • Global Population Screening Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Population Screening Report
  • Market Research Process
  • Market Research Methodology
  • Global Population Screening Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Geography
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Business
  • Market Attractiveness Analysis by Gender
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Age
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Geography (USD MN)
  • Nation Market Sales by Geography (USD MN)
  • State Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Hardware Equipment (Instrument, Kits, Chips) Market Sales by Geography (USD MN)
  • Testing / Lab (Services) Market Sales by Geography (USD MN)
  • Analytics / Interpretation (Personalization And Interpretation) Market Sales by Geography (USD MN)
  • Global Market Analysis by Business (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Research Institutes Market Sales by Geography (USD MN)
  • Diagnostic Labs Market Sales by Geography (USD MN)
  • Global Market Analysis by Gender (USD MN)
  • Male Market Sales by Geography (USD MN)
  • Female Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Mass Market Sales by Geography (USD MN)
  • Premium Market Sales by Geography (USD MN)
  • Global Market Analysis by Age (USD MN)
  • Ages <15 Market Sales by Geography (USD MN)
  • 15-65 Market Sales by Geography (USD MN)
  • Ages 65+ Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.